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Background
Traditionally the vascular effects of nitric oxide (NO) have
been attributed to the free radical form of NO (NO•) yet
the reduced form of NO (NO-) is also produced endog-
enously and vasodilates both large conduit and small
resistance-like arteries. Interestingly, NO• and NO- have
been shown to have distinct mechanisms of action in the
cardiovascular system, particularly in the heart. This study
aimed to determine if the vasorelaxant effects of NO- dif-
fered to those of NO• in rat small mesenteric resistance
arteries.
Materials and Methods
Mesenteric arteries (~350 µm diameter) were obtained
from male Sprague-Dawley rats, mounted in small vessel
myographs and isometric force and intracellular mem-
brane potential measured simultaneously. Vessels were
precontracted to ~50% of maximum (determined by
K+(124 mM)) with methoxamine. Cumulative concentra-
tion-response curves to NO• (NO gas), the NO- donor,
Angeli's salt and the NO-independent soluble guanylate
cyclase (sGC) activator, YC-1 were examined.
Results
Vasorelaxation to Angeli's salt (pEC50 = 7.02 ± 0.67 -log
M; Rmax = 96.0 ± 2.2%, n = 4) was accompanied by simul-
taneous vascular smooth muscle cell hyperpolarisation
(pEC50 = 6.82 ± 0.32, 10 µM AS -17.8 ± 4.4 mV, n = 4). In
contrast, maximal vasorelaxation to NO• (pEC50 = 6.82 ±
0.39, 92.1 ± 1.3%) was achieved before a small hyperpo-
larization response was observed at 1 µM NO• (-4.9 ± 2.3
mV, n = 5). Both relaxation and hyperpolarisation
responses to Angeli's salt were significantly attenuated (P
< 0.05, n = 5) by the NO- scavenger, L-cysteine (3 mM)
and abolished by the sGC inhibitor, ODQ (10 µM; P <
0.05, n = 4). The Kv channel inhibitor, 4-aminopyridine (1
mM) caused a 4-fold (P < 0.05, n = 4) decrease in sensitiv-
ity to Angeli's salt and abolished the hyperpolarisation
response (P < 0.05). In contrast glibenclamide (KATP chan-
nel inhibitor) and charybdotoxin (BKCa/IKCa channel
inhibitor) were without effect. YC-1 also induced vasore-
laxation and hyperpolarisation in rat small mesenteric
arteries.
Conclusion
In conclusion, in rat small mesenteric arteries, NO- medi-
ates relaxation in part via cGMP-dependent activation of
Kv channels. In contrast, NO•-mediated vasorelaxation
occurs independently of vascular smooth muscle hyper-
polarisation. Thus, the redox siblings NO• and NO- have
distinct mechanisms of vasorelaxation in resistance-like
arteries.
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